Kathrin Stavenhagen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kathrin Stavenhagen has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Richard D. Cummings
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
7 shared publications - Jamie Heimburg-Molinaro
Department of Surgery Beth Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts USA
4 shared publications - Manfred Wuhrer
Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands
4 shared publications - Akul Y. Mehta
Department of Surgery, Beth Israel Deaconess Medical Center, National Center for Functional Glycomics, Harvard Medical School , CLS 11087-3 Blackfan Circle, Boston, Massachusetts 02115
3 shared publications - Chao Gao
Harvard Medical School Center for Glycoscience, National Center for Functional Glycomics, Beth Israel Deaconess Medical Center , 330 Brookline Avenue, Boston, MA 02215, USA
3 shared publications - Manasses Jora
Rieveschl Laboratories for Mass Spectrometry Department of Chemistry University of Cincinnati PO Box 210172 Cincinnati OH 45221-0172 USA
3 shared publications
Latest Publications
- Open Access
- 4 November 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1765, 466517
Rapid and flexible analytical characterization of oligonucleotides in early drug discovery
- 4 November 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1765, 466517
Open AccessRapid and flexible analytical characterization of oligonucleotides in early drug discovery
- Open Access
- 18 February 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1746
A comparative study of ion exchange vs. ion pair chromatography for preparative separation of oligonucleotides
- 18 February 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1746
Open AccessA comparative study of ion exchange vs. ion pair chromatography for preparative separation of oligonucleotides
- Open Access
- 12 October 2023
- Published by Elsevier in Journal of Chromatography A
- Vol. 1711, 464446
Strategies for predictive modeling of overloaded oligonucleotide elution profiles in ion-pair chromatography
- 12 October 2023
- Published by Elsevier in Journal of Chromatography A
- Vol. 1711, 464446
Open AccessStrategies for predictive modeling of overloaded oligonucleotide elution profiles in ion-pair chromatography
- Open Access
- 28 October 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (43) , eabm8783
Identification and characterization of circulating immune complexes in IgA nephropathy
The underlying pathology of immunoglobulin A (IgA) nephropathy (IgAN), the most common glomerulonephritis worldwide, is driven by the deposition of immune complexes containing galactose-deficient IgA1 [Tn(+)IgA1] in the glomerular mesangium. Here, we report that novel anti-Tn circulating immune complexes (anti-Tn CICs) contain predominantly IgM, representing large macromolecular complexes of ~1.2 megadaltons to several megadalton sizes together with Tn(+)IgA1 and some IgG. These complexes are significantly elevated in sera of patients with IgAN, which contains higher levels of complement C3, compared to healthy individuals. Anti-Tn CICs are bioactive and induce specific proliferation of human renal mesangial cells. We found that these anti-Tn CICs can be dissociated with small glycomimetic compounds, which mimic the Tn antigen of Tn(+)IgA1, releasing IgA1 from anti-Tn CICs. This glycomimetic compound can also significantly inhibit the proliferative activity of anti-Tn CICs of patients with IgAN. These findings could enhance both the diagnosis of IgAN and its treatment, as specific drug treatments are now unavailable.
- 28 October 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (43) , eabm8783
Open AccessIdentification and characterization of circulating immune complexes in IgA nephropathy
The underlying pathology of immunoglobulin A (IgA) nephropathy (IgAN), the most common glomerulonephritis worldwide, is driven by the deposition of immune complexes containing galactose-deficient IgA1 [Tn(+)IgA1] in the glomerular mesangium. Here, we report that novel anti-Tn circulating immune complexes (anti-Tn CICs) contain predominantly IgM, representing large macromolecular complexes of ~1.2 megadaltons to several megadalton sizes together with Tn(+)IgA1 and some IgG. These complexes are significantly elevated in sera of patients with IgAN, which contains higher levels of complement C3, compared to healthy individuals. Anti-Tn CICs are bioactive and induce specific proliferation of human renal mesangial cells. We found that these anti-Tn CICs can be dissociated with small glycomimetic compounds, which mimic the Tn antigen of Tn(+)IgA1, releasing IgA1 from anti-Tn CICs. This glycomimetic compound can also significantly inhibit the proliferative activity of anti-Tn CICs of patients with IgAN. These findings could enhance both the diagnosis of IgAN and its treatment, as specific drug treatments are now unavailable.
- Open Access
- 27 October 2022
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 21 (12) , 100433
Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer’s Disease Brain
- 27 October 2022
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 21 (12) , 100433
Open AccessGlycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer’s Disease Brain
- Open Access
- 13 October 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (12) , 102591
N-glycosylation of mannose receptor (CD206) regulates glycan binding by C-type lectin domains
- 13 October 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (12) , 102591
Open AccessN-glycosylation of mannose receptor (CD206) regulates glycan binding by C-type lectin domains
- Open Access
- 8 October 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (41)
Cosmc deficiency causes spontaneous autoimmunity by breaking B cell tolerance
O-glycans on B cell glycoproteins controlled by X-linked Cosmc are required for B cell tolerance and preventing autoimmunity.
- 8 October 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (41)
Open AccessCosmc deficiency causes spontaneous autoimmunity by breaking B cell tolerance
O-glycans on B cell glycoproteins controlled by X-linked Cosmc are required for B cell tolerance and preventing autoimmunity.
- Open Access
- 11 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (24) , eabf6834
Differential recognition of oligomannose isomers by glycan-binding proteins involved in innate and adaptive immunity
The recognition of oligomannose-type glycans in innate and adaptive immunity is elusive due to multiple closely related isomeric glycan structures. To explore the functions of oligomannoses, we developed a multifaceted approach combining mass spectrometry assignments of oligomannose substructures and the development of a comprehensive oligomannose microarray. This defined microarray encompasses both linear and branched glycans, varying in linkages, branching patterns, and phosphorylation status. With this resource, we identified unique recognition of oligomannose motifs by innate immune receptors, including DC-SIGN, L-SIGN, Dectin-2, and Langerin, broadly neutralizing antibodies against HIV gp120, N-acetylglucosamine-1-phosphotransferase, and the bacterial adhesin FimH. The results demonstrate that each protein exhibits a unique specificity to oligomannose motifs and suggest the potential to rationally design inhibitors to selectively block these protein-glycan interactions.
- 11 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (24) , eabf6834
Open AccessDifferential recognition of oligomannose isomers by glycan-binding proteins involved in innate and adaptive immunity
The recognition of oligomannose-type glycans in innate and adaptive immunity is elusive due to multiple closely related isomeric glycan structures. To explore the functions of oligomannoses, we developed a multifaceted approach combining mass spectrometry assignments of oligomannose substructures and the development of a comprehensive oligomannose microarray. This defined microarray encompasses both linear and branched glycans, varying in linkages, branching patterns, and phosphorylation status. With this resource, we identified unique recognition of oligomannose motifs by innate immune receptors, including DC-SIGN, L-SIGN, Dectin-2, and Langerin, broadly neutralizing antibodies against HIV gp120, N-acetylglucosamine-1-phosphotransferase, and the bacterial adhesin FimH. The results demonstrate that each protein exhibits a unique specificity to oligomannose motifs and suggest the potential to rationally design inhibitors to selectively block these protein-glycan interactions.
- 5 June 2021
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 78 (14) , 5569-5585
Tumor cells express pauci- and oligomannosidic N-glycans in glycoproteins recognized by the mannose receptor (CD206)
The macrophage mannose receptor (CD206, MR) is an endocytic lectin receptor which plays an important role in homeostasis and innate immunity, however, the endogenous glycan and glycoprotein ligands recognized by its C-type lectin domains (CTLD) have not been well studied. Here we used the murine MR CTLD4–7 coupled to the Fc-portion of human IgG (MR-Fc) to investigate the MR glycan and glycoprotein recognition. We probed 16 different cancer and control tissues using the MR-Fc, and observed cell- and tissue-specific binding with varying intensity. All cancer tissues and several control tissues exhibited MR-Fc ligands, intracellular and/or surface-located. We further confirmed the presence of ligands on the surface of cancer cells by flow cytometry. To characterize the fine specificity of the MR for glycans, we screened a panel of glycan microarrays. Remarkably, the results indicate that the CTLD4-7 of the MR is highly selective for specific types of pauci- and oligomannose N-glycans among hundreds of glycans tested. As lung cancer tissue and the lung cancer cell line A549 showed intense MR-Fc binding, we further investigated the MR glycoprotein ligands in those cells by immunoprecipitation and glycoproteomic analysis. All enriched glycoproteins, of which 42 were identified, contained pauci- or oligomannose N-glycans, confirming the microarray results. Our study demonstrates that the MR CTLD4-7 is highly selective for pauci- and oligomannosidic N-glycans, structures that are often elevated in tumor cells, and suggest a potential role for the MR in tumor biology.
- 5 June 2021
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 78 (14) , 5569-5585
Tumor cells express pauci- and oligomannosidic N-glycans in glycoproteins recognized by the mannose receptor (CD206)
The macrophage mannose receptor (CD206, MR) is an endocytic lectin receptor which plays an important role in homeostasis and innate immunity, however, the endogenous glycan and glycoprotein ligands recognized by its C-type lectin domains (CTLD) have not been well studied. Here we used the murine MR CTLD4–7 coupled to the Fc-portion of human IgG (MR-Fc) to investigate the MR glycan and glycoprotein recognition. We probed 16 different cancer and control tissues using the MR-Fc, and observed cell- and tissue-specific binding with varying intensity. All cancer tissues and several control tissues exhibited MR-Fc ligands, intracellular and/or surface-located. We further confirmed the presence of ligands on the surface of cancer cells by flow cytometry. To characterize the fine specificity of the MR for glycans, we screened a panel of glycan microarrays. Remarkably, the results indicate that the CTLD4-7 of the MR is highly selective for specific types of pauci- and oligomannose N-glycans among hundreds of glycans tested. As lung cancer tissue and the lung cancer cell line A549 showed intense MR-Fc binding, we further investigated the MR glycoprotein ligands in those cells by immunoprecipitation and glycoproteomic analysis. All enriched glycoproteins, of which 42 were identified, contained pauci- or oligomannose N-glycans, confirming the microarray results. Our study demonstrates that the MR CTLD4-7 is highly selective for pauci- and oligomannosidic N-glycans, structures that are often elevated in tumor cells, and suggest a potential role for the MR in tumor biology.
- Open Access
- 10 August 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-12
Cosmc controls B cell homing
The molecular mechanisms regulating lymphocyte homing into lymph nodes are only partly understood. Here, we report that B cell-specific deletion of the X-linked gene,Cosmc, and the consequent decrease of protein O-glycosylation, induces developmental blocks of mouse B cells. After transfer into wild-type recipient,Cosmc-null B cells fail to home to lymph nodes as well as non-lymphoid organs. Enzymatic desialylation of wild-type B cells blocks their migration into lymph nodes, indicating a requirement of sialylated O-glycans for proper trafficking. Mechanistically,Cosmc-deficient B cells have normal rolling and firm arrest on high endothelium venules (HEV), thereby attributing their inefficient trafficking to alterations in the subsequent transendothelial migration step. Finally,Cosmc-null B cells have defective chemokine signaling responses. Our results thus demonstrate thatCosmcand its effects on O-glycosylation are important for controlling B cell homing.
- 10 August 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-12
Open AccessCosmc controls B cell homing
The molecular mechanisms regulating lymphocyte homing into lymph nodes are only partly understood. Here, we report that B cell-specific deletion of the X-linked gene,Cosmc, and the consequent decrease of protein O-glycosylation, induces developmental blocks of mouse B cells. After transfer into wild-type recipient,Cosmc-null B cells fail to home to lymph nodes as well as non-lymphoid organs. Enzymatic desialylation of wild-type B cells blocks their migration into lymph nodes, indicating a requirement of sialylated O-glycans for proper trafficking. Mechanistically,Cosmc-deficient B cells have normal rolling and firm arrest on high endothelium venules (HEV), thereby attributing their inefficient trafficking to alterations in the subsequent transendothelial migration step. Finally,Cosmc-null B cells have defective chemokine signaling responses. Our results thus demonstrate thatCosmcand its effects on O-glycosylation are important for controlling B cell homing.